SMALL CELL LUNG CANCER
Clinical trials for SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for hard-to-treat cancers
Disease control TerminatedThis study tested an experimental drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limited…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Experimental cancer pill tested in 23 patients, study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called NKT3447 in 23 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that no longer responds to hormone therapy, as well as other solid tumors like melanoma and lung cancer. The goal was to see if the drug could shrink tumors or slow dis…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-phase study tested a new drug called SO-C101, alone or with pembrolizumab, in 115 people with advanced solid tumors (like lung, kidney, or skin cancer) that stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study …
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Lung cancer trial adds radiation to immunotherapy – results cut short
Disease control TerminatedThis study looked at whether adding chest radiation to a standard treatment (immunotherapy plus chemotherapy) could help people with extensive-stage small-cell lung cancer live longer. About 239 adults with advanced lung cancer were planned to take part. The trial was stopped ear…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 13:51 UTC